Amoy Diagnostics Co., Ltd.
Symbol: 300685.SZ
SHZ
20.6
CNYMarkedspris i dag
34.8241
P/E-forhold
0.0000
PEG Ratio
8.13B
MRK Cap
- 0.01%
DIV Udbytte
Amoy Diagnostics Co., Ltd. (300685-SZ) Årsregnskaber
Balance
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0 | 754 | 718.7 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 259.3 | 315.9 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 478.8 | 437.6 | ||||||||||||
balance-sheet.row.inventory | 0 | 0 | 32.8 | 32.3 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 19.5 | 7.4 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 0 | 1285.1 | 1196 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 208.3 | 209.5 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 47.2 | 19.1 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 47.2 | 19.1 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | -200.7 | -248.2 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 6.5 | 20.5 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 304.5 | 323.1 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 0 | 365.8 | 323.9 | ||||||||||||
balance-sheet.row.other-assets | 0 | 1946.5 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 1946.5 | 1650.9 | 1519.9 | ||||||||||||
balance-sheet.row.account-payables | 0 | 0 | 21.3 | 24 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 0 | 5.3 | 3.1 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 8.8 | 17.1 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 48.3 | 3 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 10.3 | 11.2 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 0 | 0.6 | 0.1 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 0 | 59.2 | 15 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 1.7 | 3 | ||||||||||||
balance-sheet.row.total-liab | 0 | 0 | 151.2 | 150.3 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 398.6 | 398.2 | 221.7 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | 0 | 827.7 | 637.2 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 3.5 | 91.6 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1302.5 | 270.4 | 414.1 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1701.1 | 1499.7 | 1364.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 0 | 1650.9 | 1519.9 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 5.1 | ||||||||||||
balance-sheet.row.total-equity | 0 | 1701.1 | 1499.7 | 1369.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 0 | 58.6 | 67.6 | ||||||||||||
balance-sheet.row.total-debt | 0 | 0 | 53.6 | 6.1 | ||||||||||||
balance-sheet.row.net-debt | 0 | 0 | -441 | -396.8 |
Pengestrømsopgørelse
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 256.3 | 264.3 | 239 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 52.3 | 38.9 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 13.7 | -1.1 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | -13.7 | 1.1 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | 0 | -58.9 | -125.1 | ||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 25.9 | -132.3 | ||||||||||||
cash-flows.row.inventory | 0 | 0 | -0.6 | -10.8 | ||||||||||||
cash-flows.row.account-payables | 0 | 0 | -98 | 19.2 | ||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 13.7 | -1.1 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | -256.3 | -108.6 | 15.4 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -78.3 | -74.5 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 51.9 | 8.9 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -363.6 | -772.1 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 350.2 | 600.7 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -0.5 | -5.6 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -40.2 | -242.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -1.1 | 0 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 100.7 | 0 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -100.7 | -4.4 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -51.5 | -55.4 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | -68 | 13.5 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | -120.6 | -46.3 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 24.6 | -10 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | 0 | 12.9 | -130.8 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 244 | 243.6 | 230.7 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 244 | 230.7 | 361.6 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | 0 | 149 | 168.2 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -78.3 | -74.5 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | 0 | 70.8 | 93.6 |
Resultatopgørelse række
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1043.6 | 842.2 | 917 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 147.8 | 143.3 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 1043.6 | 694.4 | 773.8 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | -748.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 748.4 | 524.3 | 508.9 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 748.4 | 672.1 | 652.2 | ||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 6.1 | 3.1 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 1 | 0.4 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -6.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -748.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -6.4 | -1.6 | -1.3 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 1 | 0.4 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | -32.5 | 52.3 | 38.9 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | 295.1 | 287.7 | 253.2 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | 288.7 | 286.1 | 252 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | 32.5 | 21.8 | 13 | ||||||||||||
income-statement-row.row.net-income | 0 | 256.3 | 263.7 | 239.6 |
Ofte stillede spørgsmål
Hvad er Amoy Diagnostics Co., Ltd. (300685.SZ) samlede aktiver?
Amoy Diagnostics Co., Ltd. (300685.SZ) samlede aktiver er 1946538300.000.
Hvad er virksomhedens årlige omsætning?
Den årlige omsætning er N/A.
Hvad er virksomhedens profitmargin?
Virksomhedens profitmargin er 0.889.
Hvad er virksomhedens frie pengestrøm?
Det frie cash flow er 0.444.
Hvad er virksomhedens nettoprofitmargin?
Nettofortjenstmargenen er 0.246.
Hvad er firmaets samlede omsætning?
Den samlede omsætning er 0.283.
Hvad er Amoy Diagnostics Co., Ltd. (300685.SZ) nettoresultat (nettoindkomst)?
Nettoresultatet (nettoindkomsten) er 256255700.000.
Hvad er virksomhedens samlede gæld?
Den samlede gæld er 0.000.
Hvad er tallet for driftsudgifter?
Driftsudgifterne er 748437800.000.
Hvad er firmaets likviditet?
Virksomhedens likviditet er 0.000.